Ina Pharms Drug Patent Portfolio
Ina Pharms owns 1 orange book drug protected by 3 US patents Given below is the list of Ina Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8232276 | Anhydrous topical skin preparations | 24 Nov, 2020 | Expired |
| US7179475 | Anhydrous topical skin preparations | 04 Dec, 2018 | Expired |
| US8735393 | Anhydrous topical skin preparations | 04 Dec, 2018 | Expired |
Latest Legal Activities on Ina Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ina Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Maintenance Fee Reminder Mailed
Critical
| 18 Mar, 2024 | US8232276 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Dec, 2019 | US8232276 |
| Post Issue Communication - Certificate of Correction | 15 Oct, 2012 | US8232276 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 31 Jul, 2012 | US8232276 |
|
Recordation of Patent Grant Mailed
Critical
| 31 Jul, 2012 | US8232276 |
|
Issue Notification Mailed
Critical
| 11 Jul, 2012 | US8232276 |
| Dispatch to FDC | 28 Jun, 2012 | US8232276 |
|
Application Is Considered Ready for Issue
Critical
| 28 Jun, 2012 | US8232276 |
|
Issue Fee Payment Verified
Critical
| 27 Jun, 2012 | US8232276 |
|
Issue Fee Payment Received
Critical
| 27 Jun, 2012 | US8232276 |
|
Mail Notice of Allowance
Critical
| 29 Mar, 2012 | US8232276 |
|
Case Docketed to Examiner in GAU
Critical
| 27 Mar, 2012 | US8232276 |
|
Notice of Allowance Data Verification Completed
Critical
| 27 Mar, 2012 | US8232276 |
|
PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Critical
| 12 Mar, 2012 | US8232276 |
|
Terminal Disclaimer Filed
Critical
| 06 Mar, 2012 | US8232276 |
Ina Pharms's Drug Patent Litigations
Ina Pharms's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jun 22, 2009, against patent number US8232276. The petitioner , challenged the validity of this patent, with Katherine M. Burnett et al as the respondent. Click below to track the latest information on how companies are challenging Ina Pharms's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US8232276 | June, 2009 |
Decision
(17 May, 2010)
| Katherine M. Burnett et al | |
Ina Pharms's Family Patents
Ina Pharms Drug List
Given below is the complete list of Ina Pharms's drugs and the patents protecting them.
1. Xolegel
Xolegel is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8232276 | Anhydrous topical skin preparations |
24 Nov, 2020
(4 years ago)
| Expired |
| US7179475 | Anhydrous topical skin preparations |
04 Dec, 2018
(6 years ago)
| Expired |
| US8735393 | Anhydrous topical skin preparations |
04 Dec, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xolegel's drug page